½ÃÀ庸°í¼­
»óǰÄÚµå
1821584

¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå º¸°í¼­(2025³â)

Neuroprosthetics Global Market Report 2025

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

½Å°æº¸Ã¶ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ±Þ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. 2029³â¿¡´Â CAGR 14.8%¸¦ ³ªÅ¸³» 202¾ï 4,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº °³ÀÎÈ­ ÀÇÇÐ, ¸¸¼º ÁúȯÀÇ ¸¸¿¬, ¿ø°Ý ÀÇ·á ¼­ºñ½º, ¼¼°è °Ç°­ °ü¸® ÁöÃâ, ½Å°æ ÀçȰ¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(bcis), ÀΰøÁö´É(AI) ¹× ¸Ó½Å·¯´×, ºñħ½ÀÀû ½Å°æº¸Ã¶, °¨°¢ ȸº¹, ¹ÙÀÌ¿À ÇÏÀ̺긮µå ½Å°æº¸Ã¶ µîÀÌ ÀÖ½À´Ï´Ù.

ÇâÈÄ 5³â°£ÀÇ ¼ºÀå·ü 14.8%¶ó°í ÇÏ´Â ¿¹ÃøÀº ÀÌ ½ÃÀåÀÇ Àüȸ ¿¹ÃøÀ¸·ÎºÎÅÍÀÇ 0.3%¶ó°í ÇÏ´Â ¼ÒÆøÀÇ °¨¼Ò¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ÀÌ °¨¼Ò´Â ÁÖ·Î ¹Ì±¹°ú ´Ù¸¥ ±¹°¡ °£ÀÇ °ü¼¼ÀÇ ¿µÇâ ¶§¹®ÀÔ´Ï´Ù. °ü¼¼ À庮Àº ½º¿þµ§°ú È£ÁַκÎÅÍ °ø±ÞµÇ´Â ÷´Ü ½Å°æ ÀÎÅÍÆäÀ̽º¿Í ±ÙÀü ÀÇÁö¿¡ ´ëÇÑ ¹Ì±¹ÀÇ Á¢±ÙÀ» ¹æÇØÇÏ¿© Àý´ÜÀÚÀÇ À̵¿¼º ȸº¹ÀÌ Áö¿¬µÇ°í ¹°¸® ÀÇ·áºñ°¡ »ó½ÂÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ »óÈ£°ü¼¼¿Í ¹«¿ªÀÇ ±äÀå°ú ÇѰè Áõ°¡·Î ÀÎÇÑ ¼¼°è °æÁ¦¿Í ¹«¿ª¿¡ ´ëÇÑ ¾Ç¿µÇâÀ¸·Î ÀÎÇØ ±× ¿µÇâÀÌ º¸´Ù ±¤¹üÀ§ÇÏ°Ô À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

½Å°æº¸Ã¶ ½ÃÀå ¼ºÀåÀº ½Å°æ Áúȯ°ú ½Å°æ ¼Õ»óÀ¸·Î °íÅë¹Þ´Â ȯÀÚ Àα¸ Áõ°¡¿¡ ÀÇÇØ ÃËÁø µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½Å°æ ÁúȯÀº ³ú, ½Å°æ, ô¼ö¿¡ ¿µÇâÀ» ¹ÌÄ¡¸ç, ½Å°æ ¼Õ»óÀº »ç°í¿Í ¿¹Ãø ºÒ°¡´ÉÇÑ »ç°ÇÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ¸ç ¾Ð¹Ú, Àý´Ü, ½ÅÀå¿¡ ÀÇÇØ ½Å°æ¿¡ ¼Õ»óÀ»ÁÝ´Ï´Ù. ½Å°æº¸Ã¶Àº ÀÒ¾î¹ö¸° ¿îµ¿ ±â´É°ú °¨°¢ ±â´ÉÀ» ȸº¹½ÃÅ´À¸·Î½á ÀÌ·¯ÇÑ Àå¾Ö¿Í »óÇØ¸¦ ÀÔÀº ȯÀÚ¸¦ µ½´Â Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÕ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2022³â¿¡´Â ¼¼°è¿¡¼­ 5õ¸¸ ¸íÀÌ °£ÁúÀ» ¾Î¾ÒÀ¸¸ç ±× 80% °¡±îÀÌ ÁßÀú¼Òµæ±¹°¡¿¡ °ÅÁÖÇß½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ½Å°æÁúȯÀ̳ª ½Å°æ¼Õ»ó ȯÀÚ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ½Å°æº¸Ã¶ ½ÃÀåÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

  • ¼¼°èÀÇ ½Å°æº¸Ã¶ : PESTEL ºÐ¼®(Á¤Ä¡, »çȸ, ±â¼ú, ȯ°æ, ¹ýÀû ¿äÀÎ, ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ)
  • ÃÖÁ¾ ÀÌ¿ë »ê¾÷ÀÇ ºÐ¼®
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : ¼ºÀå·ü ºÐ¼®
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå ½ÇÀû : ±Ô¸ð¿Í ¼ºÀå(2019-2024³â)
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå ¿¹Ãø : ±Ô¸ð¿Í ¼ºÀå(2024-2029³â, 2034³â)
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ : Àüü ½ÃÀå ±Ô¸ð(TAM)

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¿îµ¿ ½Å°æº¸Ã¶
  • û°¢ ½Å°æº¸Ã¶/Àΰø¿Í¿ì
  • ½Ã°¢ ½Å°æº¸Ã¶/¸Á¸· ÀÓÇöõÆ®
  • ÀÎÁö ½Å°æº¸Ã¶
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : ±â¼úº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ô¼ö ÀÚ±Ø
  • ½ÉºÎ ³ú ÀÚ±Ø
  • ¹ÌÁÖ ½Å°æ ÀÚ±Ø
  • õ°ñ ½Å°æ ÀÚ±Ø
  • °æµÎ°³ ÀÚ±â ÀÚ±Ø
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : ¿ëµµº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¿îµ¿ ´º·± Àå¾Ö
  • »ý¸®Àû Àå¾Ö
  • ÀÎÁö Àå¾Ö
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : ¿îµ¿ ½Å°æº¸Ã¶ À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ±â´ÉÀû Àü±â ÀÚ±Ø(FES) ½Ã½ºÅÛ
  • ³ú-±â°è ÀÎÅÍÆäÀ̽º(BMI)
  • ½Å°æ Á¦¾î ÀǼö/ÀÇÁ·
  • ÀçȰ¿ë ¿Ü°ñ°Ý
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : û°¢ ½Å°æº¸Ã¶/Àΰø¿Í¿ì À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • Àΰø¿Í¿ì(´ÜÀÏ ¹× ´ÙÁß Ã¤³Î)
  • û°¢³ú°£ ÀÓÇöõÆ®(ABI)
  • °ñÀüµµº¸Ã»±â(BAHA)
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : ½Ã°¢ ½Å°æº¸Ã¶/¸Á¸· ÀÓÇöõÆ® À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¸Á¸· º¸Ã¶¹°
  • ±¤À¯ÀüÇÐ ÀÓÇöõÆ®
  • ½Ã°¢ ÇÇÁú ÀÓÇöõÆ®
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : ÀÎÁö ½Å°æº¸Ã¶ À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ½ÉºÎ ³ú ÀÚ±Ø(DBS) ÀåÄ¡
  • ÀÎÁö±â´É Çâ»ó ÀÓÇöõÆ®
  • ÀÎÁöÀå¾Ö¿ë ½Å°æÀÚ±Ø ÀåÄ¡

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : Áö¿ªº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå : ±¹°¡º°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ½Å°æº¸Ã¶ ½ÃÀå : °æÀï ±¸µµ
  • ½Å°æº¸Ã¶ ½ÃÀå : ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Abbott Laboratories
    • Biomet Inc.
    • Boston Scientific Corp.
    • Cochlear Ltd.
    • Demant AS

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

  • LivaNova plc
  • MED-EL GmbH
  • NDI Medical LLC
  • Neuropace Inc.
  • Nevro Corp.
  • Oticon US Inc.
  • Retina Implant AG
  • Second Sight Medical Products Inc.
  • Sonova Holding AG
  • St. Jude Medical Inc.
  • Aleva Neurotherapeutics SA
  • Axonics Modulation Technologies Inc.
  • Bionic Vision Technologies Pty Ltd.
  • Blackrock Microsystems LLC
  • Cognixion

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

  • ½Å°æº¸Ã¶ ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ±¹°¡
  • ½Å°æº¸Ã¶ ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ºÎ¹®
  • ½Å°æº¸Ã¶ ½ÃÀå(2029³â) : ¼ºÀå Àü·«
    • ½ÃÀå µ¿Çâ¿¡ ÀÇÇÑ Àü·«
    • °æÀï Àü·«

Á¦36Àå ºÎ·Ï

KTH 25.10.13

Neuroprosthetics involves the examination of neuroprostheses and brain-machine interfaces. These devices serve as substitutes for cognitive or sensory functions impaired by disorders of the nervous system. Neuroprosthetic systems consist of a range of artificial devices or systems designed to enhance the output or input of a neural system. The primary objective of neuroprosthetics is to enable individuals with brain injuries to actively engage in daily life, thereby enhancing their overall quality of life.

The key categories of neuroprosthetics include motor neuroprosthetics, auditory neuroprosthetics (including cochlear implants), visual neuroprosthetics (such as retinal implants), and cognitive neuroprosthetics. Motor neuroprosthetics (MN) function as orthoses, involving the electrical stimulation of specific brain areas to facilitate the activities and engagement of individuals who have experienced a stroke in their natural environment. Various techniques, including spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and transcranial magnetic stimulation, are applied to address diverse disorders such as motor neuron disorders, physiological disorders, and cognitive disorders.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The neuroprosthetics market research report is one of a series of new reports from The Business Research Company that provides neuroprosthetics market statistics, including neuroprosthetics industry global market size, regional shares, competitors with a neuroprosthetics market share, detailed neuroprosthetics market segments, market trends and opportunities, and any further data you may need to thrive in the neuroprosthetics industry. This neuroprosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroprosthetics market size has grown rapidly in recent years. It will grow from $10.27 billion in 2024 to $11.63 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to aging population, government initiatives, research and development, regulatory approvals, investment and funding.

The neuroprosthetics market size is expected to see rapid growth in the next few years. It will grow to $20.24 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to personalized medicine, chronic disease prevalence, telemedicine services, global healthcare expenditure, neurorehabilitation. Major trends in the forecast period include brain-computer interfaces (bcis), artificial intelligence (AI) and machine learning, non-invasive neuroprosthetics, sensory restoration, biohybrid neuroprosthetics.

The forecast of 14.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. accessibility to advanced neural interfaces and myoelectric prosthetic limbs sourced from Sweden and Australia, thereby delaying mobility restoration for amputees and elevating physical medicine costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the neuroprosthetics market is anticipated to be propelled by the increasing patient population suffering from neurological disorders and nerve injuries. Neurological disorders affect the brain, nerves, and spinal cord, while nerve injuries result from accidents or unpredictable events, causing damage to nerves through pressure, cuts, or stretching. Neuroprosthetics play a vital role in assisting patients with such disorders and injuries by restoring lost motor and sensory functions. According to the World Health Organization (WHO), 50 million people globally suffered from epilepsy in 2022, with nearly 80% residing in low and middle-income countries. Thus, the rising patient population with neurological disorders and nerve injuries is a key driver of the neuroprosthetics market.

The growth of the neuroprosthetics market is expected to be driven by the increasing prevalence of hearing loss. Hearing loss, or hearing impairment, refers to the partial or total inability to hear sounds in one or both ears. Neuroprosthetics are utilized in hearing loss cases to improve hearing, enhance speech perception, and provide auditory rehabilitation. An article by the World Health Organization estimates that over 430 million people, more than 5% of the global population, will require rehabilitation for hearing loss by 2023, with the number expected to exceed 700 million by 2050. Hence, the increasing prevalence of hearing loss is anticipated to fuel the growth of the neuroprosthetics market.

Technological advancements are influencing the neuroprosthetics market. Technological advancement is defined as the discovery of knowledge that enhances technology to offer improved products to customers. For example, in October 2022, Axoft, a US-based nanotechnology company, introduced brain-machine interface (BMI) technology. This technology features soft, flexible implants made from bioinspired materials that replicate brain tissue, ensuring long-term stability and reducing the likelihood of scarring or infection. This innovative design facilitates ultra-high bandwidth and stable measurements at the single-neuron level, significantly improving the treatment potential for neurological disorders such as epilepsy and Parkinson's disease while decreasing the need for frequent replacements.

Major companies in the neuroprosthetics market are focusing on developing innovative products, such as brain-machine interfaces (BMIs), to meet the growing demand. A brain-machine interface (BMI) is a device facilitating direct communication between the brain and a machine for control purposes. Axoft, a nanotechnology company, launched a BMI in October 2022 to enhance the treatment of neurological disorders. BMI technology involves stages such as acquiring neuronal signals, signal preprocessing, extracting relevant features, and generating control signals.

In April 2022, Blackrock Neurotech, a US-based biotechnology company specializing in brain-computer interface (BCI) technology, announced a collaboration with Phantom Neuro. This partnership is focused on creating advanced prosthetics and exoskeletons that replicate human movement in real-time, enhancing mobility and functionality for individuals with orthopedic injuries through innovative muscle-sensing implant technology. Phantom Neuro is a US-based neurotechnology company that encompasses neuroprosthetics.

Major companies operating in the neuroprosthetics market include Abbott Laboratories, Biomet Inc., Boston Scientific Corp., Cochlear Ltd., Demant AS, LivaNova plc, MED-EL GmbH, NDI Medical LLC, Neuropace Inc., Nevro Corp., Oticon US Inc., Retina Implant AG, Second Sight Medical Products Inc., Sonova Holding AG, St. Jude Medical Inc., Aleva Neurotherapeutics SA, Axonics Modulation Technologies Inc., Bionic Vision Technologies Pty Ltd., Blackrock Microsystems LLC, Cognixion, Cyberonics Inc., Intheon, Medtronic plc, MicroPort Scientific Corporation, NeuroKinetics Inc., NeuroMetrix Inc., Neuropath BV, Pixium Vision SA, SPR Therapeutics Inc., Synapse Biomedical Inc., Synchron Inc., Wise Srl

North America was the largest region in the neuroprosthetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuroprosthetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neuroprosthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The neuroprosthetics market includes revenues earned by entities by peripheral nerve, brain-computer interface, electro stimulation, neurostimulation, cochlear implant, stimulation, femoral nerve and carbon nanotube. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroprosthetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroprosthetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroprosthetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuroprosthetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Motor Neuroprosthetics; Auditory Neuroprosthetics/ Cochlear implants; Visual Neuroprosthetics/ Retinal implants; Cognitive Neuroprosthetics
  • 2) By Technique: Spinal Cord Stimulation; Deep Brain Stimulation; Vagus Nerve Stimulation; Sacral Nerve Stimulation; Transcranial Magnetic Stimulation
  • 3) By Application: Motor Neuron Disorders; Physiological Disorders; Cognitive Disorders
  • Subsegments:
  • 1) By Motor Neuroprosthetics: Functional Electrical Stimulation (FES) Systems; Brain-Machine Interfaces (BMIs); Prosthetic Limbs With Neural Control; Exoskeletons For Rehabilitation
  • 2) By Auditory Neuroprosthetics Or Cochlear Implants: Cochlear Implants (Single and Multi-Channel); Auditory Brainstem Implants (ABI); Bone-Anchored Hearing Aids (BAHA)
  • 3) By Visual Neuroprosthetics Or Retinal Implants: Retinal Prostheses; Optogenetic Implants; Visual Cortical Implants
  • 4) By Cognitive Neuroprosthetics: Deep Brain Stimulation (DBS) Devices; Cognitive Enhancement Implants; Neurostimulation Devices For Cognitive Disorders
  • Companies Mentioned: Abbott Laboratories; Biomet Inc.; Boston Scientific Corp.; Cochlear Ltd.; Demant AS; LivaNova plc; MED-EL GmbH; NDI Medical LLC; Neuropace Inc.; Nevro Corp.; Oticon US Inc.; Retina Implant AG; Second Sight Medical Products Inc.; Sonova Holding AG; St. Jude Medical Inc.; Aleva Neurotherapeutics SA; Axonics Modulation Technologies Inc.; Bionic Vision Technologies Pty Ltd.; Blackrock Microsystems LLC; Cognixion; Cyberonics Inc.; Intheon; Medtronic plc; MicroPort Scientific Corporation; NeuroKinetics Inc.; NeuroMetrix Inc.; Neuropath BV; Pixium Vision SA; SPR Therapeutics Inc.; Synapse Biomedical Inc.; Synchron Inc.; Wise Srl
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neuroprosthetics Market Characteristics

3. Neuroprosthetics Market Trends And Strategies

4. Neuroprosthetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neuroprosthetics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neuroprosthetics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neuroprosthetics Market Growth Rate Analysis
  • 5.4. Global Neuroprosthetics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neuroprosthetics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neuroprosthetics Total Addressable Market (TAM)

6. Neuroprosthetics Market Segmentation

  • 6.1. Global Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Motor Neuroprosthetics
  • Auditory Neuroprosthetics/ Cochlear implants
  • Visual Neuroprosthetics/ Retinal implants
  • Cognitive Neuroprosthetics
  • 6.2. Global Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • 6.3. Global Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Motor Neuron Disorders
  • Physiological Disorders
  • Cognitive Disorders
  • 6.4. Global Neuroprosthetics Market, Sub-Segmentation Of Motor Neuroprosthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Functional Electrical Stimulation (FES) Systems
  • Brain-Machine Interfaces (BMIs)
  • Prosthetic Limbs With Neural Control
  • Exoskeletons For Rehabilitation
  • 6.5. Global Neuroprosthetics Market, Sub-Segmentation Of Auditory Neuroprosthetics Or Cochlear Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cochlear Implants (Single and Multi-Channel)
  • Auditory Brainstem Implants (ABI)
  • Bone-Anchored Hearing Aids (BAHA)
  • 6.6. Global Neuroprosthetics Market, Sub-Segmentation Of Visual Neuroprosthetics Or Retinal Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retinal Prostheses
  • Optogenetic Implants
  • Visual Cortical Implants
  • 6.7. Global Neuroprosthetics Market, Sub-Segmentation Of Cognitive Neuroprosthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deep Brain Stimulation (DBS) Devices
  • Cognitive Enhancement Implants
  • Neurostimulation Devices For Cognitive Disorders

7. Neuroprosthetics Market Regional And Country Analysis

  • 7.1. Global Neuroprosthetics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neuroprosthetics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neuroprosthetics Market

  • 8.1. Asia-Pacific Neuroprosthetics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neuroprosthetics Market

  • 9.1. China Neuroprosthetics Market Overview
  • 9.2. China Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neuroprosthetics Market

  • 10.1. India Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neuroprosthetics Market

  • 11.1. Japan Neuroprosthetics Market Overview
  • 11.2. Japan Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neuroprosthetics Market

  • 12.1. Australia Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neuroprosthetics Market

  • 13.1. Indonesia Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neuroprosthetics Market

  • 14.1. South Korea Neuroprosthetics Market Overview
  • 14.2. South Korea Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neuroprosthetics Market

  • 15.1. Western Europe Neuroprosthetics Market Overview
  • 15.2. Western Europe Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neuroprosthetics Market

  • 16.1. UK Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neuroprosthetics Market

  • 17.1. Germany Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neuroprosthetics Market

  • 18.1. France Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neuroprosthetics Market

  • 19.1. Italy Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neuroprosthetics Market

  • 20.1. Spain Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neuroprosthetics Market

  • 21.1. Eastern Europe Neuroprosthetics Market Overview
  • 21.2. Eastern Europe Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neuroprosthetics Market

  • 22.1. Russia Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neuroprosthetics Market

  • 23.1. North America Neuroprosthetics Market Overview
  • 23.2. North America Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neuroprosthetics Market

  • 24.1. USA Neuroprosthetics Market Overview
  • 24.2. USA Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neuroprosthetics Market

  • 25.1. Canada Neuroprosthetics Market Overview
  • 25.2. Canada Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neuroprosthetics Market

  • 26.1. South America Neuroprosthetics Market Overview
  • 26.2. South America Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neuroprosthetics Market

  • 27.1. Brazil Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neuroprosthetics Market

  • 28.1. Middle East Neuroprosthetics Market Overview
  • 28.2. Middle East Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neuroprosthetics Market

  • 29.1. Africa Neuroprosthetics Market Overview
  • 29.2. Africa Neuroprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neuroprosthetics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neuroprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neuroprosthetics Market Competitive Landscape And Company Profiles

  • 30.1. Neuroprosthetics Market Competitive Landscape
  • 30.2. Neuroprosthetics Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Biomet Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Cochlear Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Demant AS Overview, Products and Services, Strategy and Financial Analysis

31. Neuroprosthetics Market Other Major And Innovative Companies

  • 31.1. LivaNova plc
  • 31.2. MED-EL GmbH
  • 31.3. NDI Medical LLC
  • 31.4. Neuropace Inc.
  • 31.5. Nevro Corp.
  • 31.6. Oticon US Inc.
  • 31.7. Retina Implant AG
  • 31.8. Second Sight Medical Products Inc.
  • 31.9. Sonova Holding AG
  • 31.10. St. Jude Medical Inc.
  • 31.11. Aleva Neurotherapeutics SA
  • 31.12. Axonics Modulation Technologies Inc.
  • 31.13. Bionic Vision Technologies Pty Ltd.
  • 31.14. Blackrock Microsystems LLC
  • 31.15. Cognixion

32. Global Neuroprosthetics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuroprosthetics Market

34. Recent Developments In The Neuroprosthetics Market

35. Neuroprosthetics Market High Potential Countries, Segments and Strategies

  • 35.1 Neuroprosthetics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neuroprosthetics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neuroprosthetics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦